SPRO logo

Spero Therapeutics (SPRO)

Profile

Full Name

Spero Therapeutics, Inc.

Ticker Symbol

SPRO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 2, 2017

Indexes

Not included

Website

http://sperotherapeutics.com

Employees

32

Key Details

Price

$0.74(-0.54%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$27.40M(-71.68% YoY)

Annual EPS

-$1.27(-395.35% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.74
SPRO price is $0.74

30-Day Relative Volume

0.61
SPRO 30-day relative volume is 0.61

Price Performance

Price Today change

-0.54%
SPRO price is down -0.54% today

Price YTD change

-28.16%
SPRO price is down -28.16% since January 1st

Price 1-year change

-49.66%
SPRO price is down -49.66% year-on-year

Price 3-year change

-87.89%
SPRO price is down -87.89% over the past 3 years

Price Range

Price All-time high

$23.64
SPRO price is currently -96.87% below its historical high of $23.64

Price 3-year low

$0.51
SPRO price is currently +46.53% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$41.37M
SPRO market capitalization is $41.37 million

Market cap 3-year change

-79.33%
SPRO market capitalization is down -79.33% over the past 3 years

Market cap All-time high

$628.51M
SPRO market capitalization is currently -93.42% below its historical high of $628.51 million

Market cap sector rank

35.36%
SPRO market capitalization is higher than 35.36% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+3.73%
SPRO shares outstanding is up +3.73% year-on-year

Shares Outstanding 3-Year Change

+70.66%
SPRO shares outstanding is up +70.66% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.83
SPRO beta is 0.83

200-day SMA

$1.10
SPRO price is currently -32.81% below its 200-day simple moving average

50-day SMA

$0.76
SPRO price is currently -2.96% below its 50-day simple moving average

RSI

53.21
SPRO 14-day relative strength index is 53.21

Volume

0.61
SPRO 30-day relative volume is 0.61

ATR

$0.08
SPRO average true range is $0.08

10-day Historical Volatility

129.27%
SPRO 10-day historical volatility is 129.27%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$27.40M
SPRO annual revenue is $27.40 million

Revenue Analysts estimate

-
SPRO annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-71.68%
SPRO annual revenue is down -71.68% year-on-year

Revenue Sector rank

37.77%
SPRO annual revenue is higher than 37.77% of companies in Healthcare sector

EPS

EPS

-$1.27
SPRO annual earnings per share is -$1.27

EPS Analysts estimate

-$2.32
SPRO annual earnings per share is currently -45.26% lower than the consensus analysts' forecast

EPS 1-year change

-395.35%
SPRO annual earnings per share is down -395.35% year-on-year

EPS Sector rank

50.54%
SPRO annual earnings per share is higher than 50.54% of companies in Healthcare sector

Profit

Gross profit

-
SPRO annual gross profit value is unknown

Gross margin

-
SPRO annual gross profit margin value is unknown

Operating profit

-$72.48M
SPRO annual operating income is -$72.48 million

Operating margin

-264.58%
SPRO annual operating profit margin is -264.58%

Net income

-$68.57M
SPRO annual net profit is -$68.57 million

Net margin

-250.28%
SPRO annual net profit margin is -250.28%

Expenses

Total expenses

$99.88M
SPRO annual total expenses is $99.88 million

Operating expenses

$99.88M
SPRO annual total operating expenses is $99.88 million

Cost of goods sold

-
SPRO annual cost of goods sold value is unknown

Selling, general & administrative expenses

$23.70M
SPRO annual SGA is $23.70 million

Depreciation and amortization

$2000.00
SPRO annual depreciation & amortization is $2000.00

Interest expense

-
SPRO annual interest expense value is unknown

Income tax

$0.00
SPRO annual income tax is $0.00

EBIT & EBITDA

EBIT

-$72.48M
SPRO annual earnings before interest & taxes is -$72.48 million

EBITDA

-$72.48M
SPRO annual EBITDA is -$72.48 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$110.54M
SPRO annual total assets is $110.54 million

Non current assets

$3.27M
SPRO annual long term assets is $3.27 million

Current assets

$107.28M
SPRO annual total current assets is $107.28 million

Cash and cash equivalents

$52.89M
SPRO annual cash & cash equivalents is $52.89 million

Accounts receivable

-
SPRO annual accounts receivable value is unknown

Inventory

-
SPRO annual inventory value is unknown

Liabilities

Total liabilities

$64.42M
SPRO annual total liabilities is $64.42 million

Long term liabilities

$15.35M
SPRO annual total long term liabilities is $15.35 million

Current liabilities

$49.07M
SPRO annual total current liabilities is $49.07 million

Accounts payable

$7.31M
SPRO annual accounts payable is $7.31 million

Debt

Total debt

$4.30M
SPRO annual total debt is $4.30 million

Total debt 1-year change

-22.48%
SPRO annual total debt is down -22.48% year-on-year

Long term debt

$2.55M
SPRO annual long term debt is $2.55 million

Short term debt

$1.75M
SPRO annual short term debt is $1.75 million

Equity & Capital

Shareholders equity

$46.12M
SPRO annual stockholders equity is $46.12 million

Book value

$46.12M
SPRO annual book value is $46.12 million

Retained earnings

-$459.64M
SPRO annual retained earnings is -$459.64 million

Working capital

$58.20M
SPRO annual working capital is $58.20 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$23.44M
SPRO annual cash flow from operations is -$23.44 million

Cash from operations 1-year change

+28.95%
SPRO annual cash flow from operations is up +28.95% year-on-year

Cash from investing

-
SPRO annual cash flow from investing activities value is unknown

Cash from investing 1-year change

-
SPRO annual cash flow from investing activities 1-year change is unknown

Cash from financing

$0.00
SPRO annual cash flow from financing activities is $0.00

Cash from financing 1-year change

-100%
SPRO annual cash flow from financing activities is down -100% year-on-year

CAPEX

CAPEX

-
SPRO annual capital expenditures value is unknown

CAPEX 1-year change

-
SPRO annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$23.44M
SPRO annual free cash flow is -$23.44 million

Free cash flow 1-year change

+28.95%
SPRO annual free cash flow is up +28.95% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
SPRO annual gross profit margin value is unknown

Operating margin

-264.58%
SPRO annual operating profit margin is -264.58%

Net margin

-250.28%
SPRO annual net profit margin is -250.28%

ROA & ROE

ROA

-46.81%
SPRO annual return on assets is -46.81%

ROE

-89.62%
SPRO annual return on equity is -89.62%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SPRO price to earnings ratio value is unknown

PE ratio Sector rank

-
SPRO price to earnings ratio is unknown

PB Ratio

PB ratio

0.90
SPRO price to book ratio is 0.90

PB ratio Sector rank

42.39%
SPRO price to book ratio is higher than 42.39% of companies in Healthcare sector

PS Ratio

PS ratio

1.51
SPRO price to sales ratio is 1.51

PS ratio Sector rank

36.28%
SPRO price to sales ratio is higher than 36.28% of companies in Healthcare sector

Enterprise value

Enterprise value

-$7.23M
SPRO enterprise value is -$7.23 million

Enterprise value Sector rank

5.79%
SPRO enterprise value is higher than 5.79% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.10
SPRO EV/EBITDA is 0.10

EV/EBITDA Sector rank

66.93%
SPRO EV/EBITDA is higher than 66.93% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.19
SPRO annual current ratio is 2.19

Quick ratio

-
SPRO annual quick ratio value is unknown

Leverage

Debt to equity

0.00
SPRO annual debt to equity ratio is 0.00

Interest coverage ratio

-
SPRO annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
SPRO piotroski f-score value is unknown

Altman Z-Score

-6.72
SPRO altman z-score is -6.72

Analyst ratings

Recent major analysts updates

Jan 30, 25 HC Wainwright & Co.
Buy
Dec 20, 24 Evercore ISI Group
In-Line
Dec 2, 24 HC Wainwright & Co.
Buy
Nov 18, 24 TD Cowen
Hold
Nov 15, 24 Cantor Fitzgerald
Overweight
Nov 4, 24 HC Wainwright & Co.
Buy
Oct 3, 24 HC Wainwright & Co.
Buy
Aug 6, 24 TD Cowen
Buy
Aug 6, 24 HC Wainwright & Co.
Buy
Aug 6, 24 Cantor Fitzgerald
Overweight

Institutional Ownership

Similar stocks

ARMP logo
Armata Pharmaceuticals (ARMP)
Advanced Biomed (ADVB)
MURA logo
Mural Oncology (MURA)
PRLD logo
Prelude Therapeutics Incorporated (PRLD)
AADI logo
Aadi Bioscience (AADI)
OPGN logo
OpGen (OPGN)
NVNO logo
enVVeno Medical (NVNO)
RANI logo
Rani Therapeutics Holdings (RANI)
AGEN logo
Agenus (AGEN)
  • What is the ticker symbol for Spero Therapeutics?
  • Does Spero Therapeutics pay dividends?
  • What sector is Spero Therapeutics in?
  • What industry is Spero Therapeutics in?
  • What country is Spero Therapeutics based in?
  • When did Spero Therapeutics go public?
  • Is Spero Therapeutics in the S&P 500?
  • Is Spero Therapeutics in the NASDAQ 100?
  • Is Spero Therapeutics in the Dow Jones?
  • When was Spero Therapeutics's last earnings report?
  • When does Spero Therapeutics report earnings?
  • Should I buy Spero Therapeutics stock now?

What is the ticker symbol for Spero Therapeutics?

The ticker symbol for Spero Therapeutics is NASDAQ:SPRO

Does Spero Therapeutics pay dividends?

No, Spero Therapeutics does not pay dividends

What sector is Spero Therapeutics in?

Spero Therapeutics is in the Healthcare sector

What industry is Spero Therapeutics in?

Spero Therapeutics is in the Biotechnology industry

What country is Spero Therapeutics based in?

Spero Therapeutics is headquartered in United States

When did Spero Therapeutics go public?

Spero Therapeutics's initial public offering (IPO) was on November 2, 2017

Is Spero Therapeutics in the S&P 500?

No, Spero Therapeutics is not included in the S&P 500 index

Is Spero Therapeutics in the NASDAQ 100?

No, Spero Therapeutics is not included in the NASDAQ 100 index

Is Spero Therapeutics in the Dow Jones?

No, Spero Therapeutics is not included in the Dow Jones index

When was Spero Therapeutics's last earnings report?

Spero Therapeutics's most recent earnings report was on Mar 27, 2025

When does Spero Therapeutics report earnings?

The next expected earnings date for Spero Therapeutics is May 15, 2025

Should I buy Spero Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page